首页 | 本学科首页   官方微博 | 高级检索  
     

顺铂加足叶乙甙联合腹腔灌注治疗恶性腹水
引用本文:仝运科 陈天法. 顺铂加足叶乙甙联合腹腔灌注治疗恶性腹水[J]. 中国肿瘤临床, 1994, 21(4): 273-275
作者姓名:仝运科 陈天法
作者单位:河南省南阳地区人民医院肿瘤科 南阳市473009
摘    要:
本文报告用顺铂加足叶乙甙联合腹腔内灌注,治疗恶性腹水16例,显效7例(43.8%),有效5例(31.3%),总有效率为75.0%(12/16).其中胃癌10例中9例有效.毒性反应主要为少数病人有轻度恶心、呕吐、骨髓抑制很轻微,未发现局部毒副作用.认为该疗法对晚期癌症病人并发恶性腹水者安全有效.

关 键 词:恶性腹水  腹腔内联合化疗  顺铂加足叶乙甙

Treatment for Malignant Ascites by Combined Intraperitoneal Infusion of Cisplatin and Etoposide
Tong Yun-Ke et al. Treatment for Malignant Ascites by Combined Intraperitoneal Infusion of Cisplatin and Etoposide[J]. Chinese Journal of Clinical Oncology, 1994, 21(4): 273-275
Authors:Tong Yun-Ke et al
Affiliation:Tong Yun-Ke et al Department of Tumor,People' s Hospital of Nanyang Prefecture,Henan Province
Abstract:
Combind chemotherapy with cisplatin 50mg and etoposide 100mg given intraperitoneally to 16 patients with malignant ascites. The response rate was 75. 0%(12/16),7 complete and 5 partial. Of 10 cases with ascites from gastric carcinoma,9 achieved remission. A few of the patients experienced mild nausea, vomitting and myelosuppres-sion. No local toxicity was found. The authors considered that this therpay was effective and safe in patients with advanced cancer complicated by malignant ascites.
Keywords:Ascites Malignancy Intraperitoneal chemotherapy Cisplatin Etoposide
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号